Taligantinib
Taligantinib (Compound Example 70) is an orally active and selective dual inhibitor targeting vascular endothelial growth factor receptor 2 (VEGFR-2) and hepatocyte growth factor receptor (c-Met). Taligantinib suppresses tumor angiogenesis and cell proliferation. Taligantinib is promising for research of solid tumors such as non-small cell lung cancer and hepatocellular carcinoma.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2243235-80-3
- Formule: C35H34F2N4O7
- Masse moléculaire:660.66
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Voir tous les produits spécifiques à Isoform VEGFR
More
Activité biologique
|
VEGFR2 |
c-Met |
Chemical Information
-
CAS No. 2243235-80-3
-
Masse moléculaire 660.66
-
Formule C35H34F2N4O7
-
SMILES
O=C(C1(CC1)C(NC2=CC=C(C(F)=C2)OC3=CC=NC4=CC(OCCCN5CCOCC5)=C6OCCOC6=C43)=O)NC7=CC=C(C=C7)F
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Taligantinib Related Classifications
HY-177134 Related Classifications
Powered by Bioz